Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchActive Not RecruitingNCT04219904
What this trial is testing

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

Who this might be right for
Stage IA Cervical CancerStage IA1 Cervical CancerStage IA2 Cervical Cancer+4 more
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00425204
What this trial is testing

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

Who this might be right for
Colorectal CancerNon-Small Cell Lung CancerProstate Cancer+2 more
Amgen 31
Large-scale testing (Phase 3)Study completedNCT00917384
What this trial is testing

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma

Who this might be right for
Gastric CancerAdenocarcinoma
Eli Lilly and Company 355
Early research (Phase 1)Study completedNCT00731952
What this trial is testing

Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
University of Virginia 21
Testing effectiveness (Phase 2)Ended earlyNCT02314052
What this trial is testing

Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07337447
What this trial is testing

Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)

Who this might be right for
Carcinoma, Neuroendocrine
Hospices Civils de Lyon 122
Not applicableApproved For MarketingNCT03089658
What this trial is testing

Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)

Who this might be right for
Metastatic Merkel Cell Carcinoma
Merck KGaA, Darmstadt, Germany
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06972758
What this trial is testing

Adjuvant Everolimus in High-Risk Hepatocellular Carcinoma After Curative Resection (SEVERANCE Trial)

Who this might be right for
CarcinomHepatocellular
Yonsei University 60
Not applicableLooking for participantsNCT07096258
What this trial is testing

EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Hedera Dx SA 1,000
Testing effectiveness (Phase 2)Study completedNCT00301548
What this trial is testing

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma
European Institute of Oncology 172
Testing effectiveness (Phase 2)Study completedNCT03486678
What this trial is testing

SHR-1210 in Combination With GEMOX in Patients With Advanced BTC

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
The First Affiliated Hospital with Nanjing Medical University 38
Not applicableActive Not RecruitingNCT03731585
What this trial is testing

Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment

Who this might be right for
Non-Small Cell Lung CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+13 more
M.D. Anderson Cancer Center 70
Testing effectiveness (Phase 2)UnknownNCT03766178
What this trial is testing

Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 45
Not applicableStudy completedNCT04779385
What this trial is testing

Cost and Effectiveness of Pressurized Intraperitoneal Aerosol Chemotherapy in Patients With Peritoneal Carcinoma.

Who this might be right for
Evaluate the Cost of a PIPAC Procedure and the Associated Hospital Stay in France
University Hospital, Grenoble 50
Not applicableLooking for participantsNCT05672043
What this trial is testing

Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China

Who this might be right for
MedulloblastomaCentral Nervous System Tumor, PediatricEpendymoma+3 more
Beijing Tiantan Hospital 400
Testing effectiveness (Phase 2)UnknownNCT03389815
What this trial is testing

A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients

Who this might be right for
Advanced Solid Tumor, Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 48
Not applicableUnknownNCT00977509
What this trial is testing

Gene Mutations in Non-Small Cell Lung Cancer Cells

Who this might be right for
Carcinoma, Non-Small-Cell Lung
National Taiwan University Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT07130032
What this trial is testing

Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade

Who this might be right for
Metastatic Non-small Cell Lung Cancer (NSCLC)Metastatic Cutaneous Melanoma
EuroCityClinic LLC 90
Not applicableUnknownNCT04223063
What this trial is testing

Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study

Who this might be right for
Bladder CancerUrothelial Carcinoma
Ross Mason 20
Not applicableWithdrawnNCT05418387
What this trial is testing

A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in Arizona

Who this might be right for
Renal Cell CarcinomaHepatocellular Carcinoma
University of Arizona
Next Page